BioCryst Pharmaceuticals
BCRX
#5073
Rank
$1.59 B
Marketcap
$7.59
Share price
-3.07%
Change (1 day)
-0.26%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : $0.44 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are $0.44 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$0.49 B-5.13%
2023-12-31$0.51 B-6.01%
2022-12-31$0.55 B-6.49%
2021-12-31$0.58 B75.72%
2020-12-31$0.33 B90.96%
2019-12-31$0.17 B19.37%
2018-12-31$0.14 B-17.62%
2017-12-31$0.17 B98.4%
2016-12-31$89.84 M-26.57%
2015-12-31$0.12 B-10.6%
2014-12-31$0.13 B180.1%
2013-12-31$48.86 M-14.93%
2012-12-31$57.43 M-30.13%
2011-12-31$82.2 M-24.89%
2010-12-31$0.10 B-23.03%
2009-12-31$0.14 B67.89%
2008-12-31$84.69 M-40.66%
2007-12-31$0.14 B108.39%
2006-12-31$68.48 M-31%
2005-12-31$99.24 M205.68%
2004-12-31$32.46 M7.88%
2003-12-31$30.09 M-27.13%
2002-12-31$41.3 M-30.11%
2001-12-31$59.09 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
$2.92 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$3.49 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$8.82 M-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$1.17 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$58.53 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.64 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$82.46 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
$1.46 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
$20.33 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA